Oncolytics Biotech (ONCY) Misses Q2 EPS by 1c

Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs